연구성과로 돌아가기
2023 연구성과별 연구자 정보 (430 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Song, Kyoung-Ho | Song, KH | 6 | Seoul Natl Univ, Coll Med, Seoul Natl Univ Bundang Hosp, Dept Internal Med, Seongnam, South Korea | 0000-0002-4517-3840 | Song, Kyoung-Ho | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Kim, Eu Suk | Kim, ES | 7 | Seoul Natl Univ, Coll Med, Seoul Natl Univ Bundang Hosp, Dept Internal Med, Seongnam, South Korea | 0000-0001-7132-0157 | Kim, Eu Suk | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Lee, Kyoung Hwa | Lee, KH | 8 | Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea | AAJ-5213-2021 | Lee, Kyoung-Hwa | 0000-0003-0033-1398 | Lee, Kyoung Hwa | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Song, Young Goo | Song, YG | 9 | Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Ahn, Jin Young | Ahn, JY | 10 | Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea | 0000-0002-3740-2826 | Ahn, Jin Young | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Choi, Jun Yong | Choi, JY | 11 | Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea | 0000-0002-2775-3315 | Choi, Jun Yong | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Choi, Won Suk | Choi, WS | 12 | Korea Univ, Coll Med, Ansan Hosp, Div Infect Dis,Dept Internal Med, Ansan, South Korea | V-2730-2017 | Choi, Won Suk | 0000-0001-5874-4764 | Choi, Won Suk | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Bae, Seongman | Bae, S | 13 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Kim, Sung-Han | Kim, SH | 14 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea | H-4368-2016 | Kim, So-Youn | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Jeong, Hye Won | Jeong, HW | 15 | Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea | AET-1982-2022 | Jeong, Hye | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Lee, Young Jae | Lee, YJ | 16 | Korea Natl Inst Hlth, Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res, Cheongju, South Korea | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Kim, Hye-Jin | Kim, HJ | 17 | Korea Natl Inst Hlth, Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res, Cheongju, South Korea | KYP-2633-2024 | Kim, Hanjin | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Choi, Ju-Yeon | Choi, JY | 18 | Korea Natl Inst Hlth, Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res, Cheongju, South Korea | AAA-4835-2022 | Choi, Jah | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Kim, Byoungguk | Kim, B | 19 | Korea Natl Inst Hlth, Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res, Cheongju, South Korea | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; | |||||
| Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants | Kim, Shin-Woo | Kim, SW | 20 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea | ksw2kms@knu.ac.kr;ktkwon@knu.ac.kr;krpeck@skku.edu;eskang@skku.edu; |
페이지 이동: